NCT07224776 2026-02-27
Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria
Brigham and Women's Hospital
Phase 1 Not yet recruiting
Clinical Trials
8 trialsNCT05673824 2026-02-09
Effect of Huaier Granule on Nephrotoxicity Associated With Targeted Therapy for Advanced Hepatobiliary Malignancies.
Fudan University
Phase 2 Completed
NCT07358520 2026-01-22
Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlotinib in Lung Cancer Patients
Fudan University
Phase 4 Not yet recruiting
NCT07355361 2026-01-21
N093
Fudan University
Phase 2 Not yet recruiting
NCT04804566 2024-04-03
Understanding Fabry Disease Therapy Choices Through the Eyes of the Patients
Amicus Therapeutics
Completed
NCT01252901 2015-05-28
Registry for Patients With Wilms' Tumor Suppressor Gene 1 (WT1) Mutation Associated Diseases
Universitätsklinikum Hamburg-Eppendorf
Completed
NCT00698659 2013-12-11
Pharmacodynamic Effects of Anti-Vascular Endothelial Growth Factor Therapy in Patients With Advanced Malignancies
National University Hospital, Singapore
Terminated
NCT00849394 2012-11-01
Evaluation of Protein in the Urine in Patients Receiving Bevacizumab
North Texas Veterans Healthcare System
Completed